aTyr Pharma Inc (LIFE)
1.58
+0.01
(+0.64%)
USD |
NASDAQ |
May 01, 16:00
1.585
0.00 (0.00%)
After-Hours: 20:00
aTyr Pharma Free Cash Flow: -37.44M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -37.44M |
| September 30, 2023 | -37.84M |
| June 30, 2023 | -40.44M |
| March 31, 2023 | -35.20M |
| December 31, 2022 | -43.53M |
| September 30, 2022 | -40.14M |
| June 30, 2022 | -38.97M |
| March 31, 2022 | -37.58M |
| December 31, 2021 | -33.27M |
| September 30, 2021 | -30.57M |
| June 30, 2021 | -24.60M |
| March 31, 2021 | -23.24M |
| December 31, 2020 | -15.50M |
| September 30, 2020 | -15.05M |
| June 30, 2020 | -13.77M |
| March 31, 2020 | -12.17M |
| December 31, 2019 | -20.09M |
| September 30, 2019 | -19.98M |
| June 30, 2019 | -22.20M |
| Date | Value |
|---|---|
| March 31, 2019 | -26.62M |
| December 31, 2018 | -31.66M |
| September 30, 2018 | -37.28M |
| June 30, 2018 | -40.11M |
| March 31, 2018 | -40.60M |
| December 31, 2017 | -43.68M |
| September 30, 2017 | -44.95M |
| June 30, 2017 | -50.37M |
| March 31, 2017 | -54.81M |
| December 31, 2016 | -53.46M |
| September 30, 2016 | -51.67M |
| June 30, 2016 | -46.77M |
| March 31, 2016 | -43.86M |
| December 31, 2015 | -37.46M |
| September 30, 2015 | -33.31M |
| June 30, 2015 | -29.24M |
| March 31, 2015 | -22.93M |
| December 31, 2014 | -23.07M |
Free Cash Flow Range, Past 5 Years
-43.53M
Minimum
Dec 2022
-12.17M
Maximum
Mar 2020
-28.50M
Average
-30.57M
Median
Sep 2021
Free Cash Flow Benchmarks
| Vaxart Inc | -72.32M |
| Allogene Therapeutics Inc | -239.25M |
| AIM ImmunoTech Inc | -21.85M |
| Protalix BioTherapeutics Inc | -2.467M |
| Armata Pharmaceuticals Inc | -55.57M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -11.06M |
| Cash from Investing (Quarterly) | 17.82M |
| Cash from Financing (Quarterly) | 6.034M |
| Free Cash Flow Per Share (Quarterly) | -0.1868 |
| Free Cash Flow Yield | -44.10% |